It was reported that a dissection occurred.The subject underwent treatment with a study device on september 05, 2019 as part of the eminent clinical trial.The target lesion was located in left distal superficial femoral artery (sfa) with 100% stenosis and was 80 mm long with a proximal reference vessel diameter of 4.7 mm and distal reference vessel diameter of 5.3 mm and was classified as tasc ii b lesion.The target lesion was treated with pre-dilatation followed by placement of a 7 mm x 100 mm study stent.Post treatment, dissection was noted, hence an additional study stent 6 mm x 80 mm was placed.Following post dilation, residual stenosis was 0%.On (b)(6) 2019, the subject was discharged with antiplatelet therapy.
|